Study of a new asthma drug for people with uncontrolled asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 80 years old.
- You have had a doctor's diagnosis of asthma for at least 12 months.
- You have had an asthma attack or flare-up in the past year.
- You are currently using a daily inhaled corticosteroid (or combination inhaler) for at least 3 months.
- You are also taking at least one other daily asthma controller medication (like a long-acting bronchodilator, Singulair, or theophylline).
- You are not a current smoker (cigarettes, marijuana, or vaping) and have not smoked for 10 pack-years or more.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This trial compares two different forms of an investigational drug to see how they are absorbed into the body. It is for healthy volunteers who want to help researchers understand the safest and most effective way to give the drug.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.